Skip to main
HSIC

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 11 analyst ratings
Hold
Strong Buy 0%
Buy 45%
Hold 45%
Sell 9%
Strong Sell 0%

Bulls say

Henry Schein Inc. has demonstrated solid revenue growth across its product segments, with medical products revenue increasing by 4.7% and dental business revenue rising by 2.7%, indicating a stable demand in the healthcare market. Additionally, the Global Technology segment contributed significantly with revenues of $173 million, reflecting a robust growth of 9.7%. Furthermore, the company's adjusted EBITDA is projected to grow in the mid-single digits in 2025 compared to 2024, signaling positive expectations for ongoing profitability and operational efficiency.

Bears say

Henry Schein Inc’s disappointing gross margin of 30.7% in the latest quarter fell below the expected 31.6%, largely due to an unfavorable product mix in its distribution and specialty products sectors. Despite achieving revenue growth in both Global Specialty Products and Global Distribution segments, the overall financial outlook is clouded by higher-than-anticipated operating costs, with SG&A expenses at 24.8% of revenue, exceeding prior estimates. The divergence between actual gross margin and expectations, alongside rising expenses, reinforces a cautious view on the company's near-term profitability and operational efficiency.

Henry Schein (HSIC) has been analyzed by 11 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 45% recommend Buy, 45% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Hold based on their latest research and market trends.

According to 11 analysts, Henry Schein (HSIC) has a Hold consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $76.55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $76.55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.